Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma
Gespeichert in:
| Weitere Verfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2015
|
| In: |
Leukemia
Year: 2015, Jahrgang: 29, Heft: 8, Pages: 1721-1729 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2015.80 |
| Online-Zugang: | Resolving-System, Volltext: http://dx.doi.org/10.1038/leu.2015.80 Verlag, Volltext: http://www.nature.com/leu/journal/vaop/naam/abs/leu201580a.html 
|
| Verfasserangaben: | E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T. Hielscher, M. Merz, B. Huegle-Doerr, A. Seckinger, D. Hose, J. Hillengass, M. S. Raab, K. Neben, H.-W. Lindemann, M. Zeis, C. Gerecke, I. G. H. Schmidt-Wolf, K. Weisel, C. Scheid, H. Salwender and H. Goldschmidt |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1499743734 | ||
| 003 | DE-627 | ||
| 005 | 20231221143421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150424s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2015.80 |2 doi | |
| 035 | |a (DE-627)1499743734 | ||
| 035 | |a (DE-576)429743734 | ||
| 035 | |a (DE-599)BSZ429743734 | ||
| 035 | |a (OCoLC)1340691104 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma |c E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T. Hielscher, M. Merz, B. Huegle-Doerr, A. Seckinger, D. Hose, J. Hillengass, M. S. Raab, K. Neben, H.-W. Lindemann, M. Zeis, C. Gerecke, I. G. H. Schmidt-Wolf, K. Weisel, C. Scheid, H. Salwender and H. Goldschmidt |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.04.2015 | ||
| 700 | 1 | |a Mai, Elias K. |d 1985- |0 (DE-588)1049182545 |0 (DE-627)781300274 |0 (DE-576)403130999 |4 oth | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 oth | |
| 700 | 1 | |a Neben, Kai |d 1969- |0 (DE-588)120842181 |0 (DE-627)080920470 |0 (DE-576)292411774 |4 oth | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 oth | |
| 700 | 1 | |a Bertsch, Uta |0 (DE-588)1026849861 |0 (DE-627)727494163 |0 (DE-576)372176224 |4 oth | |
| 700 | 1 | |a Jauch, Anna |d 1959- |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 oth | |
| 700 | 1 | |a Schurich, Bärbel |0 (DE-588)1070073237 |0 (DE-627)823264750 |0 (DE-576)429746121 |4 oth | |
| 700 | 1 | |a Merz, Maximilian |d 1985- |0 (DE-588)1023626950 |0 (DE-627)718419278 |0 (DE-576)367168251 |4 oth | |
| 700 | 1 | |a Hügle-Dörr, Barbara |0 (DE-588)1070073628 |0 (DE-627)823265528 |0 (DE-576)429746857 |4 oth | |
| 700 | 1 | |a Seckinger, Anja |d 1980- |0 (DE-588)134177371 |0 (DE-627)562118225 |0 (DE-576)278603734 |4 oth | |
| 700 | 1 | |a Hose, Dirk |d 1969- |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 oth | |
| 700 | 1 | |a Hillengaß, Jens |d 1974- |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 oth | |
| 773 | 0 | 8 | |i In |t Leukemia |d London : Springer Nature, 1997 |g 29(2015), 8, Seite 1721-1729 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma |
| 773 | 1 | 8 | |g volume:29 |g year:2015 |g number:8 |g pages:1721-1729 |a Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/leu.2015.80 |q application/pdf |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.nature.com/leu/journal/vaop/naam/abs/leu201580a.html |q application/pdf |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150424 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 25 |y j | ||
| 998 | |g 120842181 |a Neben, Kai |m 120842181:Neben, Kai |d 50000 |e 50000PN120842181 |k 0/50000/ |p 17 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 16 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 15 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |d 50000 |e 910000PH139824995 |e 910100PH139824995 |e 50000PH139824995 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 14 | ||
| 998 | |g 134177371 |a Seckinger, Anja |m 134177371:Seckinger, Anja |d 910000 |d 910100 |e 910000PS134177371 |e 910100PS134177371 |k 0/910000/ |k 1/910000/910100/ |p 13 | ||
| 998 | |g 1070073628 |a Hügle-Dörr, Barbara |m 1070073628:Hügle-Dörr, Barbara |d 910000 |d 910100 |e 910000PH1070073628 |e 910100PH1070073628 |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 998 | |g 1023626950 |a Merz, Maximilian |m 1023626950:Merz, Maximilian |d 910000 |d 910100 |e 910000PM1023626950 |e 910100PM1023626950 |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 1070073237 |a Schurich, Bärbel |m 1070073237:Schurich, Bärbel |d 910000 |d 913000 |e 910000PS1070073237 |e 913000PS1070073237 |k 0/910000/ |k 1/910000/913000/ |p 9 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 911500 |e 910000PJ1025525140 |e 911500PJ1025525140 |k 0/910000/ |k 1/910000/911500/ |p 8 | ||
| 998 | |g 1026849861 |a Bertsch, Uta |m 1026849861:Bertsch, Uta |d 910000 |d 910100 |e 910000PB1026849861 |e 910100PB1026849861 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1049182545 |a Mai, Elias K. |m 1049182545:Mai, Elias K. |d 910000 |d 910100 |e 910000PM1049182545 |e 910100PM1049182545 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1499743734 |e 2840651424 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1499743734"],"doi":["10.1038/leu.2015.80"]},"name":{"displayForm":["E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T. Hielscher, M. Merz, B. Huegle-Doerr, A. Seckinger, D. Hose, J. Hillengass, M. S. Raab, K. Neben, H.-W. Lindemann, M. Zeis, C. Gerecke, I. G. H. Schmidt-Wolf, K. Weisel, C. Scheid, H. Salwender and H. Goldschmidt"]},"language":["eng"],"relHost":[{"language":["eng"],"part":{"text":"29(2015), 8, Seite 1721-1729","issue":"8","volume":"29","year":"2015","pages":"1721-1729"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"32046699X","id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia","title":"Leukemia"}],"note":["Gesehen am 15.03.04"],"origin":[{"dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"pubHistory":["Nachgewiesen 11.1997 -"],"disp":"Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myelomaLeukemia","type":{"media":"Online-Ressource","bibl":"periodical"}}],"recId":"1499743734","type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma","title_sort":"Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma"}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"note":["Gesehen am 24.04.2015"],"person":[{"family":"Mai","display":"Mai, Elias K.","role":"oth","given":"Elias K."},{"family":"Raab","display":"Raab, Marc-Steffen","role":"oth","given":"Marc-Steffen"},{"given":"Kai","role":"oth","family":"Neben","display":"Neben, Kai"},{"family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"oth","given":"Hartmut"},{"family":"Bertsch","display":"Bertsch, Uta","role":"oth","given":"Uta"},{"family":"Jauch","display":"Jauch, Anna","given":"Anna","role":"oth"},{"given":"Bärbel","role":"oth","display":"Schurich, Bärbel","family":"Schurich"},{"display":"Merz, Maximilian","family":"Merz","given":"Maximilian","role":"oth"},{"given":"Barbara","role":"oth","display":"Hügle-Dörr, Barbara","family":"Hügle-Dörr"},{"given":"Anja","role":"oth","display":"Seckinger, Anja","family":"Seckinger"},{"family":"Hose","display":"Hose, Dirk","role":"oth","given":"Dirk"},{"display":"Hillengaß, Jens","family":"Hillengaß","given":"Jens","role":"oth"}]} | ||
| SRT | |a PHASEIIITR2015 | ||